Washington Trust Advisors »

Aldeyra Therapeutics shares owned by Washington Trust Advisors

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Washington Trust Advisors from 13F filings

Historical chart of Washington Trust Advisors investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Washington Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Washington Trust Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 3.8k 3.51

More positions owned by Washington Trust Advisors

Apple (AAPL)
Palo Alto Networks (PANW)
Quanta Services (PWR)
Visa Com Cl A (V)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Iqvia Holdings (IQV)
Booking Holdings (BKNG)
Meta Platforms Cl A (META)
Deere & Company (DE)
Alphabet Cap Stk Cl A (GOOGL)
Regeneron Pharmaceuticals (REGN)
Becton, Dickinson and (BDX)
ResMed (RMD)
Jacobs Engineering Group (J)

View all positions for Washington Trust Advisors

Top funds holding Aldeyra Therapeutics

Perceptive Advisors
Knoll Capital Management
Vanguard Group
Kennedy Capital Management
Dimensional Fund Advisors
Damian Sousa
Millennium Management
Thomas Stevens, CFA"
Bank of America Corporation
Two Sigma Advisers
Wells Fargo & Company
Deutsche Bank Aktiengesellschaft
D. E. Shaw & Co
Palo Alto Investors
Two Sigma Investments

View all funds holding Aldeyra Therapeutics